Beruflich Dokumente
Kultur Dokumente
Anaerobe
journal homepage: www.elsevier.com/locate/anaerobe
Clinical microbiology
Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710,
Republic of Korea
Asia Pacic Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea
c
Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
b
a r t i c l e i n f o
a b s t r a c t
Article history:
Received 4 March 2015
Received in revised form
25 April 2015
Accepted 4 May 2015
Available online 12 May 2015
A 61-year-old man with chronic hepatitis B and dyslipidemia visited the emergency department with a
fever and severe headache. He was diagnosed with bacterial meningitis after a lumbar puncture, and
blood culture revealed Parvimonas micra bacteremia. Although he had a history of extraction of a molar
two weeks before symptom onset, there was no evidence of abscess formation on physical examination
or imaging studies. He was successfully treated with oral metronidazole for 12 days after 9 days of
treatment with IV ceftriaxone and vancomcycin. This is the rst report of primary bacterial meningitis
caused by this organism, which indicates that this organism is capable of being a bacterial meningitis
pathogen.
2015 Elsevier Ltd. All rights reserved.
Keywords:
Parvimonas micra
Meningitis
1. Introduction
2. Case report
162
Table 1
In vitro activity of antimicrobial agents against the Parvimonas micra isolate.
Antimicrobial agent
MIC (mg/L)
Susceptibility
Ampicillina
Penicillina
Clindamycina
Ceftriaxonea
Metronidazolea
Vancomycinb
Cefoxitina
0.12
<0.06
0.25
0.12
0.12
0.5
0.25
S
S
S
S
S
S
S
4. Conclusion
This is the rst report of primary bacterial meningitis caused by
P. micra after tooth extraction and suggests that this organism can be
a bacterial meningitis pathogen, even in an immunocompetent host.
Potential conicts of interest
On behalf of all authors, the corresponding author states that
there is no conict of interest.
References
[1] D.A. Murdoch, Gram-positive anaerobic cocci, Clin. Microbiol. Rev. 11 (1998)
81e120.
[2] D. Belstrom, N.E. Fiehn, C.H. Nielsen, N. Kirkby, S. Twetman, V. Klepac-Ceraj,
B.J. Paster, P. Holmstrup, Differences in bacterial saliva prole between periodontitis patients and a control cohort, J. Clin. Periodontol. 41 (2014) 104e112.
[3] H. Uemura, K. Hayakawa, K. Shimada, M. Tojo, M. Nagamatsu, T. MiyoshiAkiyama, S. Tamura, K. Mesaki, K. Yamamoto, Y. Yanagawa, J. Sugihara,
S. Kutsuna, N. Takeshita, N. Shoda, A. Hagiwara, T. Kirikae, N. Ohmagari,
Parvimonas micra as a causative organism of spondylodiscitis: a report of two
cases and a literature review, Int. J. Infect. Dis. 23 (2014) 53e55.
[4] K.S. Leder, T.F. Barlam, A case of paraspinal abscess and diskitis due to Peptostreptococcus micros, Clin. Infect. Dis. 30 (2000) 622e623.
[5] J.P. Frat, C. Godet, G. Grollier, J.L. Blanc, R. Robert, Cervical spinal epidural
abscess and meningitis due to Prevotella oris and Peptostreptococcus micros
after retropharyngeal surgery, Intensive Care Med. 30 (2004) 1695.
[6] M. Al Masalma, F. Armougom, W.M. Scheld, H. Dufour, P.H. Roche,
M. Drancourt, D. Raoult, The expansion of the microbiological spectrum of
brain abscesses with use of multiple 16S ribosomal DNA sequencing, Clin.
Infect. Dis. 48 (2009) 1169e1178.
[7] Clinical and Laboratory Standards Institute (CLSI), Performance Standards for
Antimicrobial Susceptibility Testing; Twenty-fourth Informational Supplement, 2014 (M100eS24)(Wayne, PA).
[8] J. Brazier, D. Chmelar, L. Dubreuil, G. Feierl, M. Hedberg, S. Kalenic, E. Kononen,
B. Lundgren, H. Malamou-Ladas, E. Nagy, A. Sullivan, C.E. Nord, European
surveillance study on antimicrobial susceptibility of Gram-positive anaerobic
cocci, Int. J. Antimicrob. Agents 31 (2008) 316e320.
[9] C. Poetter, C. Pithois, S. Caty, V. Petit, J.P. Combier, P. Mourtialon, F. Mattner,
Hiding behind confusion: pleural empyema caused by Parvimonas micra,
Surg. Infect. (Larchmt) 15 (2014) 356e357.
163
[10] G.K. Taylor, L. Elliott, M.D. Sosin, S.S. Soo, Complication of etanercept treatment for rheumatoid arthritisepurulent pericarditis caused by a commensal
organism, BMJ Case Rep. (2012) 2012.
[11] P. Ubeda, J. Todoli, E. Saro, M.D. Gomez, C. Perez Belles, M. Gobernado, Subacute infectious endocarditis in prosthetic valve by Peptostreptococcus micros, Enferm. Infecc. Microbiol. Clin. 16 (1998) 101e102.
[12] T. Stoll, G. Stucki, P. Bruhlmann, M. Vogt, N. Gschwend, B.A. Michel, Infection
of a total knee joint prosthesis by peptostreptococcus micros and propionibacterium acnes in an elderly RA patient: implant salvage with longterm
antibiotics and needle aspiration/irrigation, Clin. Rheumatol. 15 (1996)
399e402.
[13] C.J. Papasian, D.H. McGregor, G.R. Hodges, J. Kennedy, Peptostreptococcal
vertebral osteomyelitis, J. Clin. Microbiol. 24 (1986) 633e635.
[14] M. Garcia Gonzalez, J.R. Muniz Montes, D. Garcia Rosado, S. Bustabad Reyes,
Multifocal hematogenous vertebral osteomyelitis due to Parvimonas micra
and a subsequent pleural effusion in a diabetic patient, Reumatol. Clin. 10
(2014) 191e192.
[15] D. van de Beek, J. de Gans, A.R. Tunkel, E.F. Wijdicks, Community-acquired
bacterial meningitis in adults, N. Engl. J. Med. 354 (2006) 44e53.
[16] S.Y. Moon, D.R. Chung, S.W. Kim, H.H. Chang, H. Lee, D.S. Jung, Y.S. Kim,
S.I. Jung, S.Y. Ryu, S.T. Heo, C. Moon, H.K. Ki, J.S. Son, K.T. Kwon, S.Y. Shin,
J.S. Lee, S.S. Lee, J.Y. Rhee, J.A. Lee, M.K. Joung, H.S. Cheong, K.R. Peck, J.H. Song,
Changing etiology of community-acquired bacterial meningitis in adults: a
nationwide multicenter study in Korea, Eur. J. Clin. Microbiol. Infect. Dis. 29
(2010) 793e800.
[17] E.J. Baron, J.M. Miller, M.P. Weinstein, S.S. Richter, P.H. Gilligan,
R.B. Thomson Jr., P. Bourbeau, K.C. Carroll, S.C. Kehl, W.M. Dunne, B. RobinsonDunn, J.D. Schwartzman, K.C. Chapin, J.W. Snyder, B.A. Forbes, R. Patel,
J.E. Rosenblatt, B.S. Pritt, A guide to utilization of the microbiology laboratory
for diagnosis of infectious diseases: 2013 recommendations by the Infectious
Diseases Society of America (IDSA) and the American Society for Microbiology
(ASM)(a), Clin. Infect. Dis. 57 (2013) e22ee121.
[18] G. Angelino, N. Cantarutti, S. Chiurchiu, D. Amodio, M. De Luca, L. Lancella,
L. Coltella, C. Russo, A. Finocchi, Fulminant Fusobacterium necrophorum
meningitis in an immunocompetent adolescent, Pediatr. Emerg. Care 28
(2012) 703e704.
[19] A. Marchand-Austin, P. Rawte, B. Toye, F.B. Jamieson, D.J. Farrell, S.N. Patel,
Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in
Ontario, 2010-2011, Anaerobe 28 (2014) 120e125.
[20] A.R. Tunkel, B.J. Hartman, S.L. Kaplan, B.A. Kaufman, K.L. Roos, W.M. Scheld,
R.J. Whitley, Practice guidelines for the management of bacterial meningitis,
Clin. Infect. Dis. 39 (2004) 1267e1284.
[21] A.H. Lau, N.P. Lam, S.C. Piscitelli, L. Wilkes, L.H. Danziger, Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives, Clin.
Pharmacokinet. 23 (1992) 328e364.